The key finding
A multidisciplinary panel has published the first comprehensive clinical practice guidelines for managing chronic subdural hematoma (cSDH), a blood collection between the brain and skull that disproportionately affects older adults. The guideline development team—comprising neurosurgeons, anesthesiologists, geriatricians, nurses, patients, and caregivers—synthesized available evidence to produce 67 recommendations spanning eight major care themes from diagnosis through recovery. Six major medical associations endorsed these guidelines, representing a paradigm shift toward coordinated, multidisciplinary care for a condition that has lacked standardized treatment approaches despite affecting an increasingly aging population.
What the study looked like
This was not a traditional research study but rather a systematic guideline development process. The team conducted comprehensive literature searches guided by clinical questions formulated through working group discussions. They employed a modified Delphi method—a structured consensus-building approach—using surveys and an in-person meeting to evaluate draft recommendations. The process explicitly included patient and caregiver perspectives alongside diverse clinical specialties including neurosurgery, anesthesiology, critical care, neuroscience nursing, and geriatric medicine. The development was overseen by a multidisciplinary steering committee, ensuring representation from various healthcare disciplines involved in cSDH care. The resulting 67 recommendations cover presentation and diagnosis, surgical decision-making, non-operative management, perioperative care including blood thinner management, surgical timing, operative techniques, and rehabilitation.
Why researchers think this happened
The guideline developers identified a critical gap: high-quality evidence for cSDH management was generally lacking across most aspects of care. While some randomized controlled trial data existed for specific surgical techniques and corticosteroid use, most treatment decisions had been based on individual institutional practices or surgeon preference rather than standardized protocols. As populations age globally, cSDH has become increasingly common, particularly among older people and those with frailty who may be taking blood-thinning medications. The condition’s growing prevalence, combined with the vulnerability of affected patients and the complexity of managing their multiple health conditions, created an urgent need for evidence-based, coordinated care pathways. The researchers recognized that optimal outcomes require collaboration across multiple specialties—from emergency medicine through neurosurgery to rehabilitation—rather than isolated neurosurgical intervention alone.
How to read this carefully
These are clinical practice guidelines, not research findings about treatment effectiveness. The authors explicitly acknowledge that high-quality evidence was lacking for most recommendations, meaning many are based on expert consensus and available lower-quality evidence rather than rigorous trials. Guidelines represent what experts believe constitutes best practice given current knowledge, but they are not prescriptive mandates and must be adapted to individual patient circumstances. The modified Delphi consensus process, while valuable for building agreement, does not generate the same level of evidence as controlled trials. Additionally, these guidelines were developed within the British healthcare context and may not fully translate to other healthcare systems. As with all medical guidelines, they will require updates as new evidence emerges from future research.
What this means for everyday life
If you or a loved one experiences symptoms like gradual confusion, headaches, or weakness—particularly after a fall or head injury weeks or months earlier—understanding that standardized care pathways now exist for cSDH may provide reassurance. These guidelines emphasize that optimal care involves multiple specialists working together, not just a neurosurgeon making isolated decisions. For older adults on blood thinners, the guidelines address the complex balance between managing bleeding risk and protecting against stroke or blood clots. Family members can now expect more consistent approaches to decisions about surgery timing, medication management, and rehabilitation planning across different hospitals. The explicit inclusion of patient and caregiver voices in developing these recommendations suggests that shared decision-making and communication should be central to cSDH care, empowering patients and families to participate meaningfully in treatment choices.